NANOXPLORE INC (GRA.CA) Stock Fundamental Analysis

TSX:GRA • CA63010G1000

2.16 CAD
-0.09 (-4%)
Last: Feb 20, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

GRA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 28 industry peers in the Chemicals industry. While GRA seems to be doing ok healthwise, there are quite some concerns on its profitability. GRA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • GRA had negative earnings in the past year.
  • GRA had a positive operating cash flow in the past year.
  • In the past 5 years GRA always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: GRA reported negative operating cash flow in multiple years.
GRA.CA Yearly Net Income VS EBIT VS OCF VS FCFGRA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M

1.2 Ratios

  • With a Return On Assets value of -6.81%, GRA perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -11.19%, GRA is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA -6.81%
ROE -11.19%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GRA.CA Yearly ROA, ROE, ROICGRA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30 -40 -50

1.3 Margins

  • With a Gross Margin value of 17.60%, GRA perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • GRA's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for GRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y60.11%
GM growth 5Y11.17%
GRA.CA Yearly Profit, Operating, Gross MarginsGRA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • GRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • GRA has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for GRA has been increased compared to 5 years ago.
  • GRA has a worse debt/assets ratio than last year.
GRA.CA Yearly Shares OutstandingGRA.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2024 2025 50M 100M 150M
GRA.CA Yearly Total Debt VS Total AssetsGRA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2024 2025 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 3.73 indicates that GRA is not in any danger for bankruptcy at the moment.
  • GRA has a Altman-Z score of 3.73. This is amongst the best in the industry. GRA outperforms 82.14% of its industry peers.
  • GRA has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of GRA (0.31) is better than 67.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 3.73
ROIC/WACCN/A
WACC14.4%
GRA.CA Yearly LT Debt VS Equity VS FCFGRA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 1.82 indicates that GRA should not have too much problems paying its short term obligations.
  • GRA has a Current ratio (1.82) which is in line with its industry peers.
  • A Quick Ratio of 1.18 indicates that GRA should not have too much problems paying its short term obligations.
  • The Quick ratio of GRA (1.18) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.18
GRA.CA Yearly Current Assets VS Current LiabilitesGRA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • GRA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.00%.
  • The Revenue for GRA has decreased by -11.90% in the past year. This is quite bad
  • The Revenue has been growing by 15.63% on average over the past years. This is quite good.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-11.9%
Revenue growth 3Y11.74%
Revenue growth 5Y15.63%
Sales Q2Q%-30.36%

3.2 Future

  • Based on estimates for the next years, GRA will show a very strong growth in Earnings Per Share. The EPS will grow by 39.69% on average per year.
  • The Revenue is expected to grow by 22.63% on average over the next years. This is a very strong growth
EPS Next Y-3.81%
EPS Next 2Y33.25%
EPS Next 3Y32.7%
EPS Next 5Y39.69%
Revenue Next Year-6.66%
Revenue Next 2Y12.83%
Revenue Next 3Y21.08%
Revenue Next 5Y22.63%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GRA.CA Yearly Revenue VS EstimatesGRA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M 200M 250M
GRA.CA Yearly EPS VS EstimatesGRA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.05 -0.05 0.1 -0.1

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • GRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year GRA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GRA.CA Price Earnings VS Forward Price EarningsGRA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as GRA.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 680.27
GRA.CA Per share dataGRA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as GRA's earnings are expected to grow with 32.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.25%
EPS Next 3Y32.7%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for GRA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NANOXPLORE INC

TSX:GRA (2/20/2026, 7:00:00 PM)

2.16

-0.09 (-4%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-10
Earnings (Next)05-11
Inst Owners11.5%
Inst Owner ChangeN/A
Ins Owners4.83%
Ins Owner ChangeN/A
Market Cap391.89M
Revenue(TTM)118.70M
Net Income(TTM)-10.71M
Analysts76
Price Target3.99 (84.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.49%
Min EPS beat(2)0.99%
Max EPS beat(2)33.99%
EPS beat(4)3
Avg EPS beat(4)3.75%
Min EPS beat(4)-53.98%
Max EPS beat(4)33.99%
EPS beat(8)5
Avg EPS beat(8)-5.15%
EPS beat(12)8
Avg EPS beat(12)-0.36%
EPS beat(16)9
Avg EPS beat(16)-22.45%
Revenue beat(2)0
Avg Revenue beat(2)-4.71%
Min Revenue beat(2)-4.83%
Max Revenue beat(2)-4.59%
Revenue beat(4)0
Avg Revenue beat(4)-7.28%
Min Revenue beat(4)-14.65%
Max Revenue beat(4)-4.59%
Revenue beat(8)0
Avg Revenue beat(8)-6.18%
Revenue beat(12)3
Avg Revenue beat(12)-3.52%
Revenue beat(16)5
Avg Revenue beat(16)-1.33%
PT rev (1m)0%
PT rev (3m)-5.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.22%
EPS NY rev (1m)0%
EPS NY rev (3m)5.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.3
P/FCF N/A
P/OCF 188.17
P/B 4.09
P/tB 4.79
EV/EBITDA 680.27
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.01
OCFY0.53%
SpS0.65
BVpS0.53
TBVpS0.45
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.81%
ROE -11.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.6%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y60.11%
GM growth 5Y11.17%
F-Score4
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 47.57
Cap/Depr 128.58%
Cap/Sales 12.49%
Interest Coverage N/A
Cash Conversion 337.15%
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.18
Altman-Z 3.73
F-Score4
WACC14.4%
ROIC/WACCN/A
Cap/Depr(3y)102.37%
Cap/Depr(5y)101.25%
Cap/Sales(3y)8.43%
Cap/Sales(5y)8.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-3.81%
EPS Next 2Y33.25%
EPS Next 3Y32.7%
EPS Next 5Y39.69%
Revenue 1Y (TTM)-11.9%
Revenue growth 3Y11.74%
Revenue growth 5Y15.63%
Sales Q2Q%-30.36%
Revenue Next Year-6.66%
Revenue Next 2Y12.83%
Revenue Next 3Y21.08%
Revenue Next 5Y22.63%
EBIT growth 1Y-17.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year133.34%
EBIT Next 3Y85.9%
EBIT Next 5Y74.42%
FCF growth 1Y-343.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.26%
OCF growth 3YN/A
OCF growth 5YN/A

NANOXPLORE INC / GRA.CA FAQ

Can you provide the ChartMill fundamental rating for NANOXPLORE INC?

ChartMill assigns a fundamental rating of 3 / 10 to GRA.CA.


Can you provide the valuation status for NANOXPLORE INC?

ChartMill assigns a valuation rating of 1 / 10 to NANOXPLORE INC (GRA.CA). This can be considered as Overvalued.


Can you provide the profitability details for NANOXPLORE INC?

NANOXPLORE INC (GRA.CA) has a profitability rating of 2 / 10.


How financially healthy is NANOXPLORE INC?

The financial health rating of NANOXPLORE INC (GRA.CA) is 4 / 10.